4//SEC Filing
Landis John B. 4
Accession 0001562180-21-001814
CIK 0001314102other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:21 PM ET
Size
7.0 KB
Accession
0001562180-21-001814
Insider Transaction Report
Form 4
Landis John B.
Director
Transactions
- Exercise/Conversion
Common Stock
2021-02-28+1,900→ 5,900 total - Exercise/Conversion
Restricted Stock Units
2021-02-28−1,900→ 0 totalExercise: $0.00From: 2021-02-28→ Common Stock (1,900 underlying)
Footnotes (1)
- [F1]Fully vested on the one-year anniversary of the grant date.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001477283
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:21 PM ET
- Size
- 7.0 KB